Literature DB >> 19631375

Protein expression profiles in osteoblasts in response to differentially shaped hydroxyapatite nanoparticles.

J L Xu1, K A Khor, J J Sui, J H Zhang, W N Chen.   

Abstract

The use of synthetic hydroxyapatite as bone substitute calls for the knowledge of the influence on adjacent cells. The aim of this study was to investigate the proteins with differential protein expression levels in the proteome of human osteoblast cell line incubated separately with various nano sized hydroxyapatite powders with different shapes and chemical compositions using iTRAQ-coupled 2D LC-MS/MS approach. In the present study, we investigated several intracellular signaling molecules involved in calcium regulation to analyze how osteoblast cells respond to dissimilar HA nanoparticles. It was found there was a significant decrease in cell population after adding the HA nanoparticles to the osteoblasts. Our results combining proteomics analysis and RT-PCR validation on targeted genes involved in calcium regulation confirmed the differences in the cellular response to dissimilar HA nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631375     DOI: 10.1016/j.biomaterials.2009.07.002

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  20 in total

Review 1.  Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications.

Authors:  Noam Eliaz; Noah Metoki
Journal:  Materials (Basel)       Date:  2017-03-24       Impact factor: 3.623

2.  Biochemical characterization of the cell-biomaterial interface by quantitative proteomics.

Authors:  W Y Tong; Y M Liang; V Tam; H K Yip; Y T Kao; K M C Cheung; K W K Yeung; Y W Lam
Journal:  Mol Cell Proteomics       Date:  2010-06-20       Impact factor: 5.911

Review 3.  The role of fetuin-A in mineral trafficking and deposition.

Authors:  Michael M X Cai; Edward R Smith; Stephen G Holt
Journal:  Bonekey Rep       Date:  2015-05-06

4.  In vitro osteoclast-like and osteoblast cells' response to electrospun calcium phosphate biphasic candidate scaffolds for bone tissue engineering.

Authors:  I Wepener; W Richter; D van Papendorp; A M Joubert
Journal:  J Mater Sci Mater Med       Date:  2012-09-11       Impact factor: 3.896

5.  Relevance of the sterilization-induced effects on the properties of different hydroxyapatite nanoparticles and assessment of the osteoblastic cell response.

Authors:  C Santos; P S Gomes; J A Duarte; R P Franke; M M Almeida; M E V Costa; M H Fernandes
Journal:  J R Soc Interface       Date:  2012-07-18       Impact factor: 4.118

Review 6.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

7.  Structural and phase characterization of bioceramics prepared from tetracalcium phosphate-monetite cement and in vitro osteoblast response.

Authors:  Radoslava Stulajterova; Lubomir Medvecky; Maria Giretova; Tibor Sopcak
Journal:  J Mater Sci Mater Med       Date:  2015-04-17       Impact factor: 3.896

8.  Crystallinity of hydroxyapatite drives myofibroblastic activation and calcification in aortic valves.

Authors:  Jennifer M Richards; Jennie A M R Kunitake; Heather B Hunt; Alexa N Wnorowski; Debra W Lin; Adele L Boskey; Eve Donnelly; Lara A Estroff; Jonathan T Butcher
Journal:  Acta Biomater       Date:  2018-03-02       Impact factor: 8.947

9.  Nanohydroxyapatite shape and its potential role in bone formation: an analytical study.

Authors:  Priya Kalia; Gema Vizcay-Barrena; Jian Ping Fan; Alice Warley; Lucy Di Silvio; Jie Huang
Journal:  J R Soc Interface       Date:  2014-01-29       Impact factor: 4.118

Review 10.  Nanoparticles and their potential for application in bone.

Authors:  Andrea Tautzenberger; Anna Kovtun; Anita Ignatius
Journal:  Int J Nanomedicine       Date:  2012-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.